Methyldopa may affect adrenal function by influencing catecholamine synthesis. Patients with adrenal conditions should have regular monitoring of adrenal hormone levels.

Methyldopa can alter catecholamine production, possibly affecting adrenal gland activity. Patients with adrenal disorders should undergo frequent hormone assessments to ensure stability.

Patients with pre-existing adrenal diseases need careful monitoring when on methyldopa, as it may disrupt hormone production. Regular endocrinological evaluations are recommended.